Shell company Concentra has found its rhythm, with Cargo Therapeutics as its latest buyout target
Kevin Tang’s Concentra Biosciences has inked its fifth buyout of the season, this time forging a deal to take out cell therapy biotech Cargo Therapeutics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.